Rotigotine Patent Expiration
Rotigotine is Used for treating restless legs syndrome and Parkinson's disease symptoms with transdermal delivery of rotigotine. It was first introduced by Ucb Inc
Rotigotine Patents
Given below is the list of patents protecting Rotigotine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Neupro | US10130589 | Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine | Dec 22, 2030 | Ucb Inc |
| Neupro | US10350174 | Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine | Dec 22, 2030 | Ucb Inc |
| Neupro | US6699498 | Transdermal therapeutic systems having improved stability and their production |
Nov 27, 2020
(Expired) | Ucb Inc |
| Neupro | US6884434 | Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
Mar 30, 2021
(Expired) | Ucb Inc |
| Neupro | US7413747 | Transdermal therapeutic system for treating Parkinsonism |
Mar 18, 2019
(Expired) | Ucb Inc |
| Neupro | US8246979 | Transdermal delivery system for the administration of rotigotine | Sep 01, 2027 | Ucb Inc |
| Neupro | US8246980 | Transdermal delivery system | Nov 27, 2025 | Ucb Inc |
| Neupro | US8617591 | Transdermal delivery system for the administration of rotigotine |
Jul 22, 2023
(Expired) | Ucb Inc |
| Neupro | US9925150 | Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine | Mar 01, 2032 | Ucb Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳